ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

QDEL vs MYGN // GROSS PROFIT MARGIN

QuidelOrtho Corporation (NASDAQ) VS. Myriad Genetics Inc. (NASDAQ) • 15-METRIC TALLY: QDEL 3 — MYGN 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QDEL VS. MYGN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC QDEL MYGN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 69.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -8.80% 0.28% -9.08 MYGN /fcf-yield <GO>
Operating Margin -33.70% -47.00% +13.30 QDEL /operating-margins <GO>
Net Profit Margin -41.50% -44.40% +2.90 QDEL /net-margins <GO>
Revenue Growth (YoY) -1.90% -1.60% -0.30 MYGN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 6/9 -2.00 MYGN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 55.3 75.5 -20.20 MYGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $943.6M $638.0M $305.6M QDEL /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR QDEL REV MYGN REV QDEL GROSS % MYGN GROSS % QDEL FCF MYGN FCF
FY 2025 $2.73B $824.5M — 69.9% -$83.0M $1.8M
FY 2024 $2.78B $837.6M — 69.9% -$112.1M -$8.7M
FY 2023 $3.00B $753.2M — — $280.2M -$110.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QDEL // BETA —
MYGN // BETA —